The Newsroom
Find out the latest about Calidi. Announcements, press coverage, publications, and company info—it’s all here.
Press Release
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
Calidi Biotherapeutics presents promising data on RTNova™, a novel systemic virotherapy technology designed to target metastatic lung cancer and other advanced cancers by overcoming immune clearance and enhancing therapeutic targeting
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics and First Light Acquisition Group (FLAG) Announce Merger Agreement to Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies
January 9, 2023
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Receives Funding from the California Institute for Regenerative Medicine (CIRM) to Advance SuperNova-1 and NeuroNova-2 Development Programs
December 13, 2022
Discover More
Discover More
Discover More
Publication
event
SuperNova (SNV)
NeuroNova
Supernova
RTNova
Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy
December 13, 2022
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
December 7, 2022
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Presents Promising Pre-Clinical Data from SuperNova-1 (SNV1), a Novel Oncolytic-Cell Based Platform, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022)
November 7, 2022
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics to Present Pre-Clinical SuperNova1 (SNV1) Data at the 2022 SITC Annual Meeting
October 12, 2022
Discover More
Discover More
Discover More
Press Release
Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO
January 1, 2019
Discover More
Press Release
Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting
November 6, 2018
Discover More
Press Release
Calidi Biotherapeutics, Inc. Granted New Patent from USPTO for Cell-Based Delivery Of Oncolytic Vaccinia Viruses
October 25, 2018
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova (NNV)
NeuroNova
Supernova
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
May 18, 2020
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova (NNV)
NeuroNova
Supernova
ASCO-SITC Clinical Immuno-Oncology Symposium February 6-8, 2020 Orlando, Florida.
February 6, 2020
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
A cell-based platform to potentiate oncolytic virus: Potential approach for cancer therapies.
February 4, 2020
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova (NNV)
NeuroNova
Supernova
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
August 19, 2019
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
August 19, 2019
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
March 27, 2019
Discover More
Discover More
Media
Scientific Advisory Board Member Interview - Ashok Srivastava, MD/PH.D.
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - W.K. Alfred Yung, MD
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Bernard Fox, PhD,
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Santosh Kesari, MD/PH.D.
February 3, 2024
Discover More
Media
Big Biz TV - Allan Camaisa
December 4, 2023
Discover More
Media
Big Biz TV - Stephen Thesing
December 4, 2023
Discover More
In The News
Calidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
October 9, 2023
Discover More
Discover More
In The News
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
October 9, 2023
Discover More
Discover More